Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Harvard Business School
Johnson and Johnson
Daiichi Sankyo
Healthtrust
Medtronic
Moodys
Fuji
Farmers Insurance

Generated: May 21, 2018

DrugPatentWatch Database Preview

BRETYLIUM TOSYLATE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Bretylium Tosylate patents expire, and when can generic versions of Bretylium Tosylate launch?

Bretylium Tosylate is a drug marketed by Abraxis Pharm, Astrazeneca, Eurohlth Intl Sarl, Hospira, Intl Medication, Luitpold, West-ward Pharms Int, Abbott, B Braun, Baxter Hlthcare, and Hospira Inc. and is included in fifteen NDAs.

The generic ingredient in BRETYLIUM TOSYLATE is bretylium tosylate. There are three drug master file entries for this compound. Additional details are available on the bretylium tosylate profile page.
Summary for BRETYLIUM TOSYLATE
US Patents:0
Applicants:11
NDAs:15
Bulk Api Vendors: 49
Clinical Trials: 121
Patent Applications: 719
DailyMed Link:BRETYLIUM TOSYLATE at DailyMed
Drug patent expirations by year for BRETYLIUM TOSYLATE
Medical Subject Heading (MeSH) Categories for BRETYLIUM TOSYLATE
Synonyms for BRETYLIUM TOSYLATE
(2-bromobenzyl)ethyldimethylammonium toluene-4-sulfonate
(2-bromobenzyl)ethyldimethylammonium tosylate
(2-bromophenyl)methyl-ethyl-dimethyl-ammonium; 4-methylbenzenesulfonate
(2-bromophenyl)methyl-ethyl-dimethylazanium; 4-methylbenzenesulfonate
(o-Bromobenzyl)ethyldimethylammonium p-toluenesulfonate
[(2-bromophenyl)methyl](ethyl)dimethylazanium 4-methylbenzene-1-sulfonate
2-Bromo-N-ethyl-N,N-dimethylbenzenemethanaminium 4-methyl-benzenesulfontate
2-Bromo-N-ethyl-N,N-dimethylbenzenemethanaminium 4-methylbenzenesulfonate
3B1-006709
4CH-007114
61-75-6
78ZP3YR353
AB2000538
AC1L1LT0
AC1Q26DL
AK-81946
AKOS015842525
AMMONIUM, (o-BROMOBENZYL)ETHYLDIMETHYL-, p-TOLUENESULFONATE
AN-23717
ANW-53884
API0001757
ASL 603
ASL-603
AX8118682
B 8406
Benzenemethanaminium, 2-bromo-N-ethyl-N,N-dimethyl-, salt with 4-methylbenzenesulfonic acid
Benzenemethanaminium, 2-bromo-N-ethyl-N,N-dimethyl-, salt with 4-methylbenzenesulfonic acid (1:1)
Benzenemethanaminium,N-dimethyl-, salt with 4-methylbenzenesulfonic acid (1:1)
Bretilio tosilato
Bretilio tosilato [DCIT]
Bretylan
Bretylate
Bretylii tosilas
Bretylii tosilas [INN-Latin]
Bretylium (tosylate)
Bretylium p-toluenesulfonate
Bretylium tosilate
Bretylium tosilate (INN)
Bretylium tosilate [INN]
Bretylium tosylate (USP)
Bretylium tosylate [USAN:BAN]
Bretylium tosylate [USAN:USP]
Bretylium Tosylate In Dextrose 5%
BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Bretylium Tosylate In Plastic Container
Bretylium tosylate, >99% (TLC), powder
Bretylium tosylate, United States Pharmacopeia (USP) Reference Standard
bretyliume tosylate
Bretylol
Bretylol (TN)
C11H17BrN.C7H7O3S
C18H24BrNO3S
CAS-61-75-6
CCG-204319
CHEBI:3173
CHEMBL1095292
CS-5728
CTK8B6650
D00645
Darenthin
Darentin
Dimethylethyl-o-bromobenzylammonium-p-toluenesulphonate
DR002497
DSSTox_CID_2685
DSSTox_GSID_22685
DSSTox_RID_76691
DTXSID1022685
EINECS 200-516-8
EU-0100224
FT-0080900
FT-0603258
HMS1570N06
HMS2097N06
HMS2235I21
HY-12961A
KB-48455
KS-0000012R
Lopac-B-8406
LS-16927
MFCD00038731
MLS000028635
MolPort-003-940-544
N-(2-Bromobenzyl)-N,N-dimethylethaminium 4-methylbenzenesulfote
N-(2-bromobenzyl)-N,N-dimethylethanaminium 4-methylbenzenesulfonate
N-[(2-bromophenyl)methyl]-N,N-dimethylethanaminium 4-methylbenzenesulfonate
N-Ethyl-N-(o-bromobenzyl)-N,N-dimethylammonium Tosylate
N-Ethyl-N-o-bromobenzyl-N,N-dimethylammonium tosylate
NCGC00016119-01
NCGC00016119-02
NCGC00016119-03
NCGC00016119-04
NCGC00024457-02
NSC 62164
NSC-62164
NSC62164
Opera_ID_1513
Ornid
RW1157
SCHEMBL40898
SMR000058647
SR-01000000254
SR-01000000254-2
ST24031295
TC-061525
Tosilate de bretylium
Tosilate de bretylium [INN-French]
Tosilato de bretilio
Tosilato de bretilio [INN-Spanish]
Tox21_110308
UNII-78ZP3YR353
V2113
WLN: ER B1K2&1&1 &OSWR D1

US Patents and Regulatory Information for BRETYLIUM TOSYLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm BRETYLIUM TOSYLATE bretylium tosylate INJECTABLE;INJECTION 070134-001 Apr 29, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Baxter Hlthcare BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER bretylium tosylate INJECTABLE;INJECTION 019837-002 Apr 12, 1989 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Hospira BRETYLIUM TOSYLATE bretylium tosylate INJECTABLE;INJECTION 019030-001 Apr 29, 1986 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Astrazeneca BRETYLIUM TOSYLATE bretylium tosylate INJECTABLE;INJECTION 071152-001 Aug 10, 1987 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Express Scripts
Healthtrust
Mallinckrodt
Johnson and Johnson
Moodys
Deloitte
Fish and Richardson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.